This website uses cookies

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Essential cookies enable basic functions and are necessary for the website to function properly.
Statistics cookies collect information anonymously. This information helps us to understand how our visitors use our website.
Marketing cookies are used by third parties or publishers to display personalized advertisements. They do this by tracking visitors across websites.

Dear Patient,

This website will provide you with a comprehensive overview of an investigational treatment option for advanced neuroendocrine tumors (NETs) being investigated in the phase III clinical trials COMPETE and COMPOSE. The information outlined on this website does not replace a consultation with your primary care physician.

If you are interested in participating in one of these research studies, please reach out to your attending physician who will provide you with detailed information and determine whether you meet the eligibility criteria to enter the trial.

Sincerely,

Your COMPETE and COMPOSE Teams

Neuroendocrine Tumors

More

COMPETE Trial

More

n.c.a. Lutetium-177-Edotreotide

More

Radiopharmaceutical Therapy (RPT)

More

COMPOSE Trial

More

Clinical Trials

More